Radiolysis-Associated Decrease in Radiochemical Purity of ¹⁷⁷Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process

The radiolytic degradation of vector molecules is a major factor affecting the shelf life of therapeutic radiopharmaceuticals. The development of time-stable dosage forms of radiopharmaceuticals is the key to their successful implementation in clinical practice. Using [¹⁷⁷Lu]Lu-PSMA-617 m...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Anton Larenkov, Iurii Mitrofanov, Ekaterina Pavlenko, Marat Rakhimov
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2023-02-01
Rangatū:	Molecules
Ngā marau:	therapeutic radiopharmaceuticals radiolysis stability radical scavengers antioxidants radiochemical purity
Urunga tuihono:	https://www.mdpi.com/1420-3049/28/4/1884
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!